Polycystic ovary syndrome (PCOS) is extremely prevalent and probably constitutes the most frequently encountered endocrine (hormone) disorder in women.

Slides:



Advertisements
Similar presentations
Ovarian Ageing and Fertility
Advertisements

Pregnancy and Lactation
Infertility and PCOS Erinn Myers, M4 Department of Obstetrics and Gynecology University of Tennessee Health Science Center January 28, 2007.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
IN THE NAME OF GOD Elham Faghihimani endocrinologist.
Valerie Robinson, DO. Polycystic Ovarian Syndrome (PCOS) is a disorder that causes menstrual and ovulation irregularities, androgen excess, and infertility.
PCOS Polycystic Ovary Syndrome
Coronary Heart Disease Risk Profile of Women with PCOS: Collision of Evidence and Assumptions Evelyn Talbott, Dr.P.H. Kim Sutton-Tyrrell, Dr.P.H. Lewis.
The Metabolic Syndrome in PCOS. An international consensus group of the European Society for Human Reproduction and Embryology and the American Society.
Role of Anti-Mullerian hormone in prediction of Assisted Reproductive Technology outcomes Leili Safdarian M.D. Khadigeh Khosravi M.D. Marzieh Agha Hosseini.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Insulin sensitizing agents use in pregnancy and as therapy in PCOS
INFERTILITY ASSOCIATED WITH PCOS Dr. Norlia Bahauddin Hospital Kajang.
Ovaries and the Fertility Cycle
THE IMPACT OF FEMALE OBESITY ON IN VITRO FERTILIZATION OUTCOMES Prof. Dr. İdris KOÇAK ONDOKUZ MAYIS UNIVERSITY DEPARTMENT OF OBSTETRICS AND GYNECOLOGY,
Obesity M.A.Kubtan MD - FRCS M.A.Kubtan1. 2  Pulmonary Disease  Fatty Liver Disease  Orthopedic Disorders  Gallbladder Disease  Psychological Impact.
OVARIES Both a reproductive organ, and an endocrine gland.
Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA.
HDR Women’s Health 11 th April 2012 By Dr Mahya Mirfattahi GP ST3 POLYCYSTIC OVARY SYNDROME A SUMMARY OF RCOG GREEN-TOP GUIDELINE.
Polycystic Ovary Syndrome Melissa McCarthy June 1, 2010.
Polycystic Ovary Syndrome
Ku č era, E..  Normal menstrual cycle  21 – 36 days interval between bleeding  duration of bleeding is 2 – 8 days  average is 5 days  blood loss.
POLYCYSTIC OVARY SYNDROME A COMMON FEMALE ENDOCRINE DISEASE SBI4U-01 Mr. Gajewski Bashour Yazji Jason Antrobus Narayan Wagle.
Polycystic Ovarian Disorder Max Brinsmead MB BS PhD August 2014.
The Effects of Inositol on Women with Polycystic Ovary Syndrome(PCOS)
ANOVULATION CEM FICICIOGLU, M.D, Ph.D.,AA.,MBA.
Pathogenesis (etiology?) Hypersecretion of adrenal androgens? Hypersecretion of ovarian androgens? A genetic disorder with an autosomal dominant mode.
Adrenal Medulla Gland.
Investigating infertile couple
In women resistant to clomiphene citrate, or metformin combined with clomiphene, the next step has been gonadotropin therapy. While this treatment causes.
OVARIES Both a reproductive organ, and an endocrine gland.
PROFESSOR ZEINAB ABOTALIB Consultant Obstetrics & Gynaecology and infertility.
Biology, Grade 12 SBI4U Female Reproductive System.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Polycystic Ovarian Syndrome Lindsay White. Polycystic Ovarian Syndrome (PCOS) is the most common cause of female infertility.
Metabolic Syndrome Endocrine Block 1 Lecture Dr. Usman Ghani.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
PCOS: Polycystic Ovarian Syndrome
POLYCYSTIC OVARY SYNDROME
Endometrial biopsy in subfertile women undergoing intrauterine insemination (IUI) cycles improves pregnancy rates Tumanyan A, Tchzmachyan R, Grigoryan.
Prevention Diabetes.
Polycystic Ovary Syndrome (PCOS)
Endocrine Block 1 Lecture Dr. Usman Ghani
Endocrine Block Dr. Usman Ghani
Polycystic Ovary Disease
GLYPICAN-4 LEVELS IN RELATION WITH HORMONAL AND METABOLIC PROFILE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME Doç.Dr.Özlem ALTINKAYA.
Coagulation/Fibrinolytic Factors in PCOS
Polycystic ovarian syndrome Obesity and Insulin resistance
Reproduction-Related Disorders
Aging and Infertility. Part 2. National Infertility Centre
The Menstrual Cycle Introduction Hormones 1 Summary
Endocrine Block 1 Lecture Dr. Usman Ghani
Biomarkers of ovarian cancer and cysts
Biomarkers of ovarian cancer and cysts
Both a reproductive organ, and an endocrine gland
THE OVARIES AND THE TESTES
A reproductive organ, and an endocrine gland
Pathophysiology of Ovarian Function in the Human Female
Prevention Diabetes Dr Abir Youssef 29/11/2018.
CEM FICICIOGLU, M.D, Ph.D.,AA.,MBA
Type 2 diabetes: Overlap of clinical conditions
Both a reproductive organ, and an endocrine gland
Menstrual cycle Lecture 2.
Polycystic Ovary Syndrome (PCOS)
Zehong Zhou, Rong Li, Jie Qiao  Reproductive BioMedicine Online 
Paper 2 Biology Coordination and Control
Solutions to Infertility
Presentation transcript:

Polycystic ovary syndrome (PCOS) is extremely prevalent and probably constitutes the most frequently encountered endocrine (hormone) disorder in women of reproductive age. www.femelife.com

www.femelife.com Polycystic ovary syndrome (PCOS) is extremely prevalent and probably constitutes the most frequently encountered endocrine (hormone) disorder in women of reproductive age. Having the disorder may significantly impact the quality of life of women during the reproductive years, and it contributes to morbidity and mortality by the time of menopause.  

www.femelife.com What are the disorders associated with PCOS? PCOS women are at increased risk for coronary heart disease and type 2 diabetes mellitus. Their risk factors include central obesity, hypertriglyceridemia, low levels of high-density lipoprotein (HDL) cholesterol, hypertension, and elevated fasting plasma glucose concentrations. PCOS women should undergo screening for hypertension, abnormal lipid profiles, insulin resistance, and reproductive disorders including cancer of endometrium.

www.femelife.com What is PAO? A subgroup of women (up to 30%) may have subtle abnormalities resembling PCOS called PAO. While PCOS occurs in at least 5% of the population, the isolated finding of polycystic-appearing ovaries (PAO), which meets the classic ultra-sonographic criteria, occurs in 16–25% of the normal population without evidence of the full-blown syndrome. These findings suggest that important yet silent abnormalities may exist in otherwise normal women who have a trait of PCOS (namely PAO).

www.femelife.com What is the most important reproductive concern in women with PCOS? The most frustrating reproductive concern for women with PCOS is pregnancy loss. The spontaneous abortion rate in PCOS is approximately one third of all pregnancies. This is at least double the rate for recognized early abortions in normal women (12–15%). Reasons for this are unclear although hypotheses include elevated LH levels, deficient progesterone secretion, abnormal embryos from atretic oocytes, and an abnormal endometrium.

www.femelife.com How PCOS negatively impact psychosocial development of young women? Women with PCOS, particularly those with hirsutism, have an increased prevalence of reactive depression and minor psychological abnormalities. There is also evidence of increased psychological stress and an increased catecholamine response to provoked stress. The overall quality of life is decreased in hirsute women. The presence of hirsutism and menstrual irregularities, especially in younger patients, is extremely distressing and has a significant negative impact on their psychosocial development.

www.femelife.com Which cancer has increased risk in women with PCOS? Women with PCOS are at increased risk of endometrial cancer. Chronic unopposed estrogen exposure is probably the proximate risk factor. This may be confounded by obesity, hypertension, and diabetes, which are known correlates of endometrial cancer risk. It is imperative to screen all women with PCOS, even those who are considered too young to develop endometrial hyperplasia and carcinoma.

www.femelife.com Can low grade inflammation be a risk factor of PCOS? Women with PCOS have significantly increased CRP concentrations relative to those in healthy women with normal menstrual rhythm and normal androgens. Inflammatory marker like CRP concentrations is more with PCOS. It correlates with the degree of obesity and inversely with insulin sensitivity, although not with total testosterone concentrations.

www.femelife.com Which is a better predictor of metabolic syndrome in PCOS? Obesity, a key determinant of insulin concentrations, appeared to have an independent effect on risk for the metabolic syndrome. In Anovulatory PCOS women a waist circumference of >83.5 cm along with biochemical evidence of hyperandrogenism is a powerful predictor of the presence of metabolic syndrome and insulin resistance. Age and central obesity (waist-hip ratio/waist circumference) are better predictors of metabolic syndrome in women with PCOS compared to other parameters including BMI.

www.femelife.com How Metformin helps in PCOS? Metformin is the most thoroughly investigated insulin-lowering agent used to treat PCOS; it enhances insulin sensitivity in the liver, where it inhibits hepatic glucose production, and in muscle, where it improves glucose uptake and use. The persistence of regular ovulatory menstrual cycles in the 6 months after the end of treatment demonstrates that metformin treatment provides lasting benefits. All girls maintain a BMI <25 kg/m2, and this can play a role in normal ovulation menstrual cycles.

www.femelife.com What is the role of AMH in diagnosis of PCOS? Serum anti-Mullerian hormone (AMH), produced in the ovaries by small follicles, is usually elevated in women with PCOS and correlates with the severity of this syndrome. AMH plays an important role in inhibiting follicular development by decreasing the sensitivity of the follicles to FSH and by inhibiting granulosa cell aromatase. Serum AMH appears as a sensitive and specific parameter that predict PCOS than antral follicle count and ovarian volume.

www.femelife.com What is the source of DHEA in PCOS? Serum DHEAS has been found to be elevated in some women with polycystic ovary syndrome (PCOS). In PCOS, it has been found that there are actually two different sources of androgens, the ovary and the adrenal. In women with PCOS, the theca cells are overactive and proliferate excessively, producing too much testosterone. Unfortunately, in 40-50% of women with PCOS, there is also another source of androgens, which is the adrenal glands. The adrenal glands produce all of the DHEA in the body.

www.femelife.com What causes PCOS in non-obese women? All women with PCOS are not obese. Between 20–50% of women with PCOS are normal weight or thin, and the pathophysiology of the disorder in these women may differ from that in obese women. It has been suggested that PCOS develops in non-obese women because of a hypothalamic-pituitary defect that results in increased release of LH, and that insulin plays no role in the disorder. These women tend to have an increased waist to hip ratio and are insulin resistant and hyperinsulinemic compared to their normal counterparts.

www.femelife.com How the lean PCOS are treated? Even normal weight and thin women with PCOS respond to pharmacological measures to improve insulin sensitivity, such as administration of agents like metformin, with decreases in ovarian androgen production and serum androgens. Administration of myoinositol (3 g per day) reduce luteinizing hormone (LH), high-sensitivity C-reactive protein (hs-CRP) (inflammation), and androgens, as well as improve insulin tolerance test, in lean patients with PCOS.

www.femelife.com How infertility in PCOS treated?   Lifestyle modification is very important in the treatment for PCOS, because weight loss and exercise have been shown to lead to improved fertility and the lowering of androgen levels. Ovarian stimulation along with insulin sensitizers help in many instances. IVF is an alternative option in PCOS. GnRH antagonist protocol appears to significantly reduce the rate of severe OHSS in these women. The average number of oocytes recovered is higher but rate of immature oocytes is more and fertilization rate is lower in the PCOS group.

www.femelife.com Does IVM help in PCOS? In-vitro maturation treatment can now be offered as a successful option to infertile women with polycystic ovaries or polycystic ovary syndrome. It is possible to combine natural cycle in-vitro fertilization with immature oocyte retrieval followed by in-vitro maturation, and thus offer women with various causes of infertility reasonable pregnancy and implantation rates without recourse to ovarian stimulation.

www.femelife.com What is the effect of bariatric surgery in PCOS?   Bariatric surgery has been increasingly popular to treat morbid obesity associated with PCOS. In the larger population as the surgery has become safer with primarily a laparoscopic approach and selection of a healthier population for surgery, long-term survival is now superior with versus without the surgery.